insights_auto
Outlook: 36.8% bullish·10.5% bearish
Go to analysischevron_right
AMGN34:BVMF
Amgen Inc. BDR
R$86,25
0,00%
(0,00) 1D
28 Okt., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
R$84,05
High
R$86,49
Low
R$84,05
Mkt. cap
244,27 mjd
Avg. vol.
401,00
Volume
1,32 k
52-wk high
R$86,49
52-wk low
R$47,76
Shares outstanding
540,63 m
No. of employees
32 k
Open
R$84,05
High
R$86,49
Low
R$84,05
Mkt. cap
244,27 mjd
Avg. vol.
401,00
Volume
1,32 k
52-wk high
R$86,49
52-wk low
R$47,76
Shares outstanding
540,63 m
No. of employees
32 k
News stories
From web sources and news partners
Traders Union
·
7 uur gelede
Amgen stock edges higher as Q3 2026 results report date announcement
www.marketscreener.com
·
8 uur gelede
AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS
Yahoo Finance
·
1 dag gelede
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 k
Founded1980
HeadquartersThousand Oaks, Kalifornië, Verenigde State van Amerika
Sector-
Websiteamgen.com